| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 66.21B | 63.52B | 56.59B | 50.62B | 48.68B | 41.69B |
| Gross Profit | 18.22B | 14.50B | 7.17B | 5.68B | 12.03B | 13.03B |
| EBITDA | 11.62B | 6.72B | 735.00M | -648.00M | 7.88B | 7.81B |
| Net Income | 8.38B | 4.67B | -188.00M | -1.29B | 1.61B | 5.58B |
Balance Sheet | ||||||
| Total Assets | 120.40B | 111.62B | 103.36B | 97.99B | 99.44B | 125.99B |
| Cash, Cash Equivalents and Short-Term Investments | 9.67B | 5.24B | 5.87B | 4.91B | 4.77B | 7.12B |
| Total Debt | 8.09B | 8.09B | 7.94B | 7.96B | 7.98B | 7.83B |
| Total Liabilities | 92.91B | 90.25B | 85.73B | 80.63B | 74.31B | 95.77B |
| Stockholders Equity | 27.50B | 21.44B | 17.77B | 17.49B | 25.18B | 30.22B |
Cash Flow | ||||||
| Free Cash Flow | 8.64B | 8.72B | 3.96B | 4.70B | 4.77B | 5.18B |
| Operating Cash Flow | 8.83B | 8.93B | 4.23B | 5.12B | 5.12B | 5.49B |
| Investing Cash Flow | -6.98B | -8.25B | -3.00B | -1.73B | 510.00M | -3.44B |
| Financing Cash Flow | -1.85B | -697.00M | -1.24B | -3.42B | -5.24B | -2.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $123.37B | 13.09 | 14.06% | 1.22% | 6.68% | -1.78% | |
78 Outperform | $38.64B | 11.33 | 20.07% | 1.55% | 7.11% | 22.52% | |
78 Outperform | $133.19B | 12.45 | 34.23% | 2.20% | 18.35% | 32.36% | |
78 Outperform | $65.16B | 11.48 | 19.81% | 1.49% | 6.75% | 30.83% | |
76 Outperform | $25.71B | 12.26 | 14.53% | 2.10% | -0.63% | -30.68% | |
74 Outperform | $54.38B | 6.73 | 34.63% | 1.91% | 7.07% | 100.42% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
Allstate announced that its November 2025 monthly update detailing estimated catastrophe losses and policies in force has been made available to investors via its website. The release signals the company’s ongoing practice of providing regular transparency on catastrophe exposure and policy trends, information that is closely watched by investors and other stakeholders assessing Allstate’s risk profile and operating performance.
The most recent analyst rating on (ALL) stock is a Buy with a $254.00 price target. To see the full list of analyst forecasts on Allstate stock, see the ALL Stock Forecast page.
Gregg M. Sherrill, who has been a member of the board of directors of Allstate since 2017 and served as the board’s Lead Director since 2021, will retire effective November 21, 2025. Richard T. Hume, a board member since 2020, will take over as Lead Director on the same date. Sherrill’s retirement is not due to any disagreement with the company.
The most recent analyst rating on (ALL) stock is a Buy with a $244.00 price target. To see the full list of analyst forecasts on Allstate stock, see the ALL Stock Forecast page.
In October 2025, Allstate released its monthly update detailing estimated catastrophe losses and the number of policies in force, which is available on their investor website. This announcement provides stakeholders with crucial information on the company’s financial health and operational status, reflecting its ongoing risk management and market positioning efforts.
The most recent analyst rating on (ALL) stock is a Buy with a $244.00 price target. To see the full list of analyst forecasts on Allstate stock, see the ALL Stock Forecast page.
Allstate has announced its estimated catastrophe losses and policies in force for September 2025. This release provides insights into the company’s financial performance and operational impact, reflecting its ongoing commitment to transparency with stakeholders.
The most recent analyst rating on (ALL) stock is a Buy with a $223.00 price target. To see the full list of analyst forecasts on Allstate stock, see the ALL Stock Forecast page.
Allstate Corporation announced significant changes to its senior leadership team, effective October 1, 2025. Mario Rizzo will become the Chief Operating Officer, Jesse E. Merten will succeed him as President of Property-Liability, and John E. Dugenske will serve as interim Chief Financial Officer while maintaining his role as President of Investments and Corporate Strategy. These leadership changes are expected to impact the company’s operations and strategic direction, with adjustments in executive compensation reflecting their new roles.
The most recent analyst rating on (ALL) stock is a Hold with a $233.00 price target. To see the full list of analyst forecasts on Allstate stock, see the ALL Stock Forecast page.